Biopharmaceutical manufacturing

Show results for

Unknown (158)
Genomics (6)
Proteomics (5)
Transcriptomics (2)
Clinical (1)
Metabolomics (1)

Organisms

Archaea (5)
Bacteria (5)
Betaherpesvirinae (5)
Borrelia (5)
Botrytis cinerea (5)
Candida albicans (5)
Clostridium perfringens (5)
Cnidaria (5)
Eukaryota (5)
Fasciola (5)
Fungi (5)
Hepatitis B virus (5)
Human betaherpesvirus 5 (5)
Influenza C virus (5)
Japanese encephalitis virus group (5)
Miscanthus x giganteus (5)
Mycobacterium tuberculosis (5)
Orthoflavivirus (5)
Panicum virgatum (5)
Platyhelminthes (5)
Rattus (5)
Saccharomyces cerevisiae (5)
Salmonella enterica subsp. enterica (5)
Schizosaccharomyces pombe (5)
Severe acute respiratory syndrome coronavirus 2 (5)
Staphylococcus aureus (5)
Streptococcus pneumoniae (5)
Toxoplasma gondii (5)
Mus musculus (1)
Cricetulus griseus (1)

Organisms

Cricetulus griseus (2)

Repository

ENA (6)
pride (5)
biostudies-arrayexpress (1)
geo (1)
MetaboLights (1)

Tissue

Cell culture (4)

Disease

Carcinoma (1)

Technology Type

Mass Spectrometry (5)
Bottom-up proteomics (3)
Data-dependent acquisition (3)
Mass spectrometry (1)
Data-independent acquisition (1)
Shotgun proteomics (1)

Instrument Platform

Liquid Chromatography MS - positive - reverse phase (1)
Liquid Chromatography MS - negative - reverse phase (1)

Publication Date

2024 (3)
2023 (2)
2014 (1)
2019 (1)
2025 (1)

CHEBI ID

CHEBI:192131 (1)
CHEBI:175580 (1)
CHEBI:188534 (1)
CHEBI:190916 (1)
CHEBI:31412 (1)
CHEBI:31471 (1)
CHEBI:188607 (1)
CHEBI:159024 (1)
CHEBI:82361 (1)
CHEBI:186830 (1)
CHEBI:64183 (1)
CHEBI:87651 (1)
CHEBI:181883 (1)
CHEBI:91544 (1)
CHEBI:174783 (1)
CHEBI:79734 (1)
CHEBI:2927 (1)
CHEBI:68682 (1)
CHEBI:135658 (1)
CHEBI:183823 (1)
CHEBI:189527 (1)
CHEBI:189488 (1)
CHEBI:189455 (1)
CHEBI:32323 (1)
CHEBI:36420 (1)
CHEBI:34031 (1)
CHEBI:75169 (1)
CHEBI:170072 (1)
CHEBI:183107 (1)
CHEBI:88497 (1)

Metabolite Name

(-)-Spinosyn A (1)
(+)-Estrone (1)
(+/-)-Methoprene (1)
(1R,9S,12S,13R,14S,17R,18Z,21S,23S,24S,25S,27R)-17-Allyl-1,14,25-trihydroxy-12-{(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-propen-2-yl}-23-methoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacos-18-ene-2,3,10,16-tetrone (1)
(21R)-27-Amino-24-hydroxy-24-oxido-18-oxo-19,23,25-trioxa-24lambda~5~-phosphaheptacosan-21-yl (13Z)-13-docosenoate (1)
(2E,4E,6E,8E,10E,12E,14E)-15-(4-Hydroxy-2,6,6-trimethyl-1-cyclohexen-1-yl)-4,9,13-trimethyl-2,4,6,8,10,12,14-pentadecaheptaenal (1)
(2R)-1-{[(2-Aminoethoxy)(hydroxy)phosphoryl]oxy}-3-hydroxy-2-propanyl (13Z)-13-docosenoate (1)
(2R)-2,3-Bis[(1Z,11Z)-1,11-octadecadien-1-yloxy]propyl 2-(trimethylammonio)ethyl phosphate (1)
(2Z,4E,6E,8E,10E,12E,14Z)-15-(6-Hydroxy-4,4,7a-trimethyl-2,4,5,6,7,7a-hexahydro-1-benzofuran-2-yl)-2,6,11-trimethyl-2,4,6,8,10,12,14-hexadecaheptaenal (1)
(3alpha,5alpha,17beta)-17-Hydroxyandrostan-3-yl beta-D-glucopyranuronate (1)
(3E,5E,7E,9Z,11E,13E,15Z,17E)-18-(4-Hydroxy-2,6,6-trimethyl-1-cyclohexen-1-yl)-3,7,12,16-tetramethyl-3,5,7,9,11,13,15,17-octadecaoctaen-2-one (1)
(6R,10S)-13-[(2S)-6-Hydroxy-2,5,7,8-tetramethyl-3,4-dihydro-2H-chromen-2-yl]-2,6,10-trimethyltridecanoic acid (1)
[8-Formyl-5-methoxy-2-methyl-2-(4-methyl-2-oxo-3-penten-1-yl)-3,4-dihydro-2H-chromen-7-yl]methyl (9E,12E)-9,12-octadecadienoate (1)
{2-[2-(Isobutyryloxy)-4-methylphenyl]-2-oxiranyl}methyl 2-methylbutanoate (1)
1-(1H-Imidazol-5-yl)-3-(phosphonooxy)-2-propanone (1)
1-(9Z-hexadecenoyl)-2-(9Z,12Z-octadecadienoyl)-sn-glycerol (1)
1,1-Dichloroethene (1)
1-[(9Z)-tetradecenoyl]-2-[(5Z,8Z,11Z,14Z)-icosatetraenoyl]-sn-glycerol (1)
11-Nitro-1-undecene (1)
12-deoxyphorbol 20-acetate 13-(2-methylbutanoate) (1)
14,18-Dihydroxy-12-oxo-9,13,15-octadecatrienoic acid (1)
17,21-Dihydroxypregnenolone (1)
1-aminocyclopropanecarboxylic acid (ACPC) (1)
1-oleoyl-2-arachidonoyl-sn-glycerol-3-phosphoethanolamine (1)
2,3-Dinor-11b-PGF2alpha (1)
2,3-Dinor-8-epi-prostaglandin F2¬¶√ (1)
2,4-Bis(2,4-dimethylphenyl)-6-(2-hydroxy-4-n-octyloxyphenyl)-1,3,5-triazine (1)
2,6-Diamino-4-hexenoic acid (1)
2444643WXK (1)
246I1D7TDL (1)

First Public Date

2025 (3)
2026 (1)
2020 (1)
2019 (1)

Study status

Completed (1)

Study type

Transcription profiling by array (1)
Interventional (1)

Release Date

2022 (25)
2025 (21)
2023 (21)
2021 (15)
2024 (12)
2020 (12)
2019 (12)
2015 (7)
2026 (6)
2017 (6)
2018 (5)
2016 (3)
2012 (3)
2011 (3)
2014 (2)
2013 (1)
2010 (1)
2009 (1)
2007 (1)
2006 (1)
2003 (1)

Lab affiliation

National Institute for Bioprocessing Research and Training (3)
Laboratoire de Spectrométrie de Masse BioOrganique (LSMBO), Université de Strasbourg, CNRS, IPHC, UMR 7178, 25 Rue Becquerel, F-67087 Strasbourg, France (1)
School of Chemical, Materials and Biological Engineering; University of Sheffield. (1)

Location

Australia (1)

Keyword

Tislelizumab (1)
Metastatic (1)
Advanced (1)

Previous page
1 / 18
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 18
Next page

Sort by:

Relevance

Page size

Towards a cleaner CHO chassis: systematic knockout of host cell proteins for efficient biopharmaceutical manufacturing.

Not available

S-EPMC12902299 | biostudies-literature

Transformative roles of digital twins from drug discovery to continuous manufacturing: pharmaceutical and biopharmaceutical perspectives.

Not available

S-EPMC12516570 | biostudies-literature

Biomanufacturing readiness levels [BRL]-A shared vocabulary for biopharmaceutical technology development and commercialization.

Not available

S-EPMC9826509 | biostudies-literature

Parylene C Coating Efficacy Studies: Enhancing Biocompatibility of 3D Printed Polyurethane Parts for Biopharmaceutical and CGT Applications.

Not available

S-EPMC11337162 | biostudies-literature

The utility of hydrogen/deuterium exchange mass spectrometry in biopharmaceutical comparability studies.

Not available

S-EPMC3164548 | biostudies-literature

k-mer-Based Metagenomics Tools Provide a Fast and Sensitive Approach for the Detection of Viral Contaminants in Biopharmaceutical and Vaccine Manufacturing Applications Using Next-Generation Sequencing.

Not available

S-EPMC8546726 | biostudies-literature

Biopharmaceutical Financialization and Public Funding of Medical Countermeasures (MCMs) in Canada During the COVID-19 Pandemic.

Not available

S-EPMC10462233 | biostudies-literature

X-ray sterilization of biopharmaceutical manufacturing equipment-Extractables profile of a film material and copolyester Tritan™ compared to gamma irradiation.

Not available

S-EPMC9286515 | biostudies-literature

Emerging antibody-based products for infectious diseases: Planning for metric ton manufacturing.

Not available

S-EPMC9103258 | biostudies-literature

Genetic Drivers of Chinese Hamster Ovary Cell Proliferation Revealed by Functional Genomics

Cell lines used in biopharmaceutical manufacturing are engineered to optimize protein yield, quality, and production speed. Cellular growth rate is a key bottleneck in the development of high-yield biopharmaceutical production cell lines. To systematically uncover genetic drivers of proliferation in...

PRJEB91812 | ENA

Previous page
1 / 18
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 18
Next page

Sort by:

Relevance

Page size

173 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

CHEBI ID

Metabolite Name

First Public Date

Study status

Study type

Release Date

Lab affiliation

Location

Tags

Keyword

OmicsDI is part of the ELIXIR infrastructure

Tweets